Patent · US Active

Heterocyclic derivatives as modulators of kinase activity

US9580443B2 · kind B2 · utility

5Cited by

0References

14Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Ruoxi Lan · Waltham, US
Bayard R. Huck · Sudbury, US
Xiaoling Chen · Sharon, US
Yufang Xiao · Lexington, US

Key dates

Filing date	Nov 15, 2013
Grant date	Feb 28, 2017
Priority date	—
Expiry date	Nov 15, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61N2005/1098
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides novel imidazol-piperidinyl derivatives of the formula (I)in which R1, R2, W, X1, X2, X3, X4 and n have the meanings indicated in formula I, and their manufacture and use for the treatment of hyperproliferative diseases, such as cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.